無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血液関連医薬品の世界市場:血液製品・貧血用医薬品・その他の血液疾患用医薬品

Hematology Drugs Global Market Report 2019

発行 The Business Research Company 商品コード 531329
出版日 ページ情報 英文 300 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.39円で換算しております。
Back to Top
血液関連医薬品の世界市場:血液製品・貧血用医薬品・その他の血液疾患用医薬品 Hematology Drugs Global Market Report 2019
出版日: 2019年01月01日 ページ情報: 英文 300 Pages
概要

当レポートでは、世界の血液関連医薬品の市場を調査し、市場の定義と概要、市場への各種影響因子の分析、薬剤区分・地域・国別の動向と市場規模の推移と予測、マクロ経済因子・ヘルスケア市場全体・各種産業指標との比較、競合環境、企業プロファイルなどをまとめています。

第1章 市場の特徴

第2章 市場規模・成長率

  • 市場成長:これまでの経緯
    • 成長推進因子
    • 成長抑制因子
  • 市場成長:予測
    • 成長推進因子
    • 成長抑制因子

第3章 PESTLE分析

第4章 顧客情報

第5章 血液関連医薬品市場の分析:区分別

  • 世界市場の実績:区分別
    • 血液製品
    • 貧血用医薬品
    • その他の血液疾患用医薬品
  • 世界市場の推移と予測:区分別
  • 市場動向・戦略

第6章 血液関連医薬品市場の分析:地域・国別分析

  • 世界市場の実績:地域別
  • 世界市場の推移と予測:地域別
  • 市場実績:国別
  • 市場の推移と予測:国別
  • 世界の医薬品市場の実績:区分・地域別
  • 世界の医薬品市場の実績:区分・国別

第7章 マクロ経済因子と市場の比較

  • 市場規模のGDPに占める割合
  • 一人当たりの平均支出額

第8章 マクロ経済因子と市場の比較:国別

  • 市場規模のGDPに占める割合:国別
  • 一人当たりの平均支出額:国別

第9章 産業指標と市場の比較

  • 世界の薬剤師数:国別
  • 市場収益 vs 薬剤師数:国別
  • 世界の医薬品会社数:国別
  • 市場収益 vs 医薬品会社数:国別
  • 世界のR&D/製品開発への平均支出額:国別
  • 市場収益 vs R&D/製品開発への平均支出額:国別
  • 世界のジェネリック&ブランド売上の割合:国別
  • 市場収益 vs ジェネリック&ブランド売上の割合:国別
  • サラセミアの有病者数:国別

第10章 アジア太平洋市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 中国
  • インド
  • 日本
  • オーストラリア

第11章 西欧市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン

第12章 東欧市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • ロシア

第13章 北米市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 米国

第14章 南米市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • ブラジル

第15章 中東市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別

第16章 アフリカ市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別

第17章 競合環境

  • 企業プロファイル
  • Baxalta
  • Bayer Ag
  • Novo Nordisk
  • Pfizer Inc.
  • Biogen Idec

第18章 主要M&A:血液関連医薬品市場

第19章 市場背景:医薬品市場

第20章 医薬品産業のファイナンシャルマージン

第21章 付録

目次

Hematology Drugs Market Global Report 2019 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global hematology drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the hematology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Hematology Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The hematology drugs market section of the report gives context. It compares the hematology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, hematology drugs indicators comparison.

Scope

Markets Covered: Blood Products, Anemia And Other Blood Disorder Drugs

Companies Mentioned: Novo Nordisk A/S, Shire Plc, Bayer AG, Daiichi Sankyo Company, Biogen Inc

Metrics Covered: Number of Enterprises, Number of Employees

Countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, hematology drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Hematology Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Hematology Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Hematology Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Hematology Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Hematology Drugs Market Trends And Strategies

8. Hematology Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Hematology Drugs Market Regional Analysis

  • 9.1. Global Hematology Drugs Market, 2018, By Region, Value ($ Billion)
  • 9.2. Global Hematology Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 9.3. Global Hematology Drugs Market, Growth And Market Share Comparison, By Region

10. Hematology Drugs Market Segmentation

  • 10.1. Global Hematology Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
    • 10.1.1. Blood Products
    • 10.1.2. Anemia And Other Blood Disorder Drugs

11. Hematology Drugs Market Metrics

  • 11.1. Hematology Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • 11.2. Per Capita Average Hematology Drugs Market Expenditure, 2014 - 2022, Global

12. Asia-Pacific Hematology Drugs Market

  • 12.1. Asia-Pacific Hematology Drugs Market Overview
  • 12.2. Asia-Pacific, Hematology Drugs Market, 2018, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Hematology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Hematology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Hematology Drugs Market Metrics
    • 12.5.1. Per Capita Average Hematology Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
  • 12.6. Asia-Pacific Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 12.7. Asia-Pacific Hematology Drugs Market: Country Analysis
    • 12.7.1. China Hematology Drugs Market
      • 12.7.1.1. China Hematology Drugs Market Overview
      • 12.7.1.2. China Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.1.3. China Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.1.4. China Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.2. Australia Hematology Drugs Market
      • 12.7.2.1. Australia Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.2.2. Australia Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.2.3. Australia Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.3. Hong Kong Hematology Drugs Market
      • 12.7.3.1. Hong Kong Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.4. India Hematology Drugs Market
      • 12.7.4.1. India Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.4.2. India Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.4.3. India Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.5. Indonesia Hematology Drugs Market
      • 12.7.5.1. Indonesia Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.6. Japan Hematology Drugs Market
      • 12.7.6.1. Japan Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.6.2. Japan Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.6.3. Japan Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.7. Malaysia Hematology Drugs Market
      • 12.7.7.1. Malaysia Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.8. New Zealand Hematology Drugs Market
      • 12.7.8.1. New Zealand Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.9. Philippines Hematology Drugs Market
      • 12.7.9.1. Philippines Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.10. Singapore Hematology Drugs Market
      • 12.7.10.1. Singapore Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.11. South Korea Hematology Drugs Market
      • 12.7.11.1. South Korea Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.12. Thailand Hematology Drugs Market
      • 12.7.12.1. Thailand Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.13. Vietnam Hematology Drugs Market
      • 12.7.13.1. Vietnam Hematology Drugs Market, 2014 - 2022, Value ($ Billion)

13. Western Europe Hematology Drugs Market

  • 13.1. Western Europe Hematology Drugs Market Overview
  • 13.2. Western Europe, Hematology Drugs Market, 2018, By Country, Value ($ Billion)
  • 13.3. Western Europe, Hematology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 13.4. Western Europe, Hematology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Hematology Drugs Market Metrics
    • 13.5.1. Per Capita Average Hematology Drugs Expenditure, 2014 - 2022, Western Europe Countries
  • 13.6. Western Europe Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 13.7. Western Europe Hematology Drugs Market: Country Analysis
    • 13.7.1. Austria Hematology Drugs Market
      • 13.7.1.1. Austria Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.2. Belgium Hematology Drugs Market
      • 13.7.2.1. Belgium Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.3. Denmark Hematology Drugs Market
      • 13.7.3.1. Denmark Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.4. Finland Hematology Drugs Market
      • 13.7.4.1. Finland Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.5. France Hematology Drugs Market
      • 13.7.5.1. France Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.5.2. France Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.5.3. France Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.6. Germany Hematology Drugs Market
      • 13.7.6.1. Germany Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.6.2. Germany Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.6.3. Germany Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.7. Ireland Hematology Drugs Market
      • 13.7.7.1. Ireland Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.8. Italy Hematology Drugs Market
      • 13.7.8.1. Italy Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.8.2. Italy Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.8.3. Italy Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.9. Netherlands Hematology Drugs Market
      • 13.7.9.1. Netherlands Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.10. Norway Hematology Drugs Market
      • 13.7.10.1. Norway Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.11. Portugal Hematology Drugs Market
      • 13.7.11.1. Portugal Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.12. Spain Hematology Drugs Market
      • 13.7.12.1. Spain Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.12.2. Spain Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.12.3. Spain Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.13. Sweden Hematology Drugs Market
      • 13.7.13.1. Sweden Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.14. Switzerland Hematology Drugs Market
      • 13.7.14.1. Switzerland Hematology Drugs Market2013 - 2022, Value ($ Billion)
    • 13.7.15. UK Hematology Drugs Market
      • 13.7.15.1. UK Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.15.2. UK Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.15.3. UK Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Hematology Drugs Market

  • 14.1. Eastern Europe Hematology Drugs Market Overview
  • 14.2. Eastern Europe, Hematology Drugs Market, 2018, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Hematology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Hematology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Hematology Drugs Market Metrics
    • 14.5.1. Per Capita Average Hematology Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
  • 14.6. Eastern Europe Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 14.7. Eastern Europe Hematology Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Hematology Drugs Market,
      • 14.7.1.1. Czech Republic Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.2. Poland Hematology Drugs Market
      • 14.7.2.1. Poland Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.3. Romania Hematology Drugs Market
      • 14.7.3.1. Romania Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.4. Russia Hematology Drugs Market
      • 14.7.4.1. Russia Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 14.7.4.2. Russia Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 14.7.4.3. Russia Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

15. North America Hematology Drugs Market

  • 15.1. North America Hematology Drugs Market Overview
  • 15.2. North America, Hematology Drugs Market, 2018, By Country, Value ($ Billion)
  • 15.3. North America, Hematology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 15.4. North America, Hematology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 15.5. North America, Hematology Drugs Market Metrics
    • 15.5.1. Per Capita Average Hematology Drugs Expenditure, 2014 - 2022, North America Countries
  • 15.6. North America Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 15.7. North America Hematology Drugs Market: Country Analysis
    • 15.7.1. Canada Hematology Drugs Market
      • 15.7.1.1. Canada Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.2. Mexico Hematology Drugs Market
      • 15.7.2.1. Mexico Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.3. USA Hematology Drugs Market
      • 15.7.3.1. USA Hematology Drugs Market Overview
      • 15.7.3.2. USA Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 15.7.3.3. USA Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 15.7.3.4. USA Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

16. South America Hematology Drugs Market

  • 16.1. South America Hematology Drugs Market Overview
  • 16.2. South America, Hematology Drugs Market, 2018, By Country, Value ($ Billion)
  • 16.3. South America, Hematology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 16.4. South America, Hematology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 16.5. South America, Hematology Drugs Market Metrics
    • 16.5.1. Per Capita Average Hematology Drugs Expenditure, 2014 - 2022, South America Countries
  • 16.6. South America Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 16.7. South America Hematology Drugs Market: Country Analysis
    • 16.7.1. Argentina Hematology Drugs Market
      • 16.7.1.1. Argentina Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.2. Brazil Hematology Drugs Market
      • 16.7.2.1. Brazil Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 16.7.2.2. Brazil Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 16.7.2.3. Brazil Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 16.7.3. Chile Hematology Drugs Market
      • 16.7.3.1. Chile Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.4. Colombia Hematology Drugs Market
      • 16.7.4.1. Colombia Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.5. Peru Hematology Drugs Market
      • 16.7.5.1. Peru Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.6. Venezuela Hematology Drugs Market
      • 16.7.6.1. Venezuela Hematology Drugs Market, 2014 - 2022, Value ($ Billion)

17. Middle East Hematology Drugs Market

  • 17.1. Middle East Hematology Drugs Market Overview
  • 17.2. Middle East, Hematology Drugs Market, 2018, By Country, Value ($ Billion)
  • 17.3. Middle East, Hematology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 17.4. Middle East, Hematology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Hematology Drugs Market Metrics
    • 17.5.1. Per Capita Average Hematology Drugs Expenditure, 2014 - 2022, Middle East Countries
  • 17.6. Middle East Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 17.7. Middle East Hematology Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Hematology Drugs Market
      • 17.7.1.1. Saudi Arabia Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.2. Israel Hematology Drugs Market
      • 17.7.2.1. Israel Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.3. Turkey Hematology Drugs Market
      • 17.7.3.1. Turkey Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.4. UAE Hematology Drugs Market
      • 17.7.4.1. UAE Hematology Drugs Market, 2014 - 2022, Value ($ Billion)

18. Africa Hematology Drugs Market

  • 18.1. Africa Hematology Drugs Market Overview
  • 18.2. Africa, Hematology Drugs Market, 2018, By Country, Value ($ Billion)
  • 18.3. Africa, Hematology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 18.4. Africa, Hematology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Hematology Drugs Market Metrics
    • 18.5.1. Per Capita Average Hematology Drugs Expenditure, 2014 - 2022, Africa Countries
  • 18.6. Africa Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 18.7. Africa Hematology Drugs Market: Country Analysis
    • 18.7.1. Egypt Hematology Drugs Market
      • 18.7.1.1. Egypt Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.2. Nigeria Hematology Drugs Market
      • 18.7.2.1. Nigeria Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.3. South Africa Hematology Drugs Market
      • 18.7.3.1. South Africa Hematology Drugs Market, 2014 - 2022, Value ($ Billion)

19. Hematology Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. Novo Nordisk A/S
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Company Hematology Drugs Market Structure And Strategy
      • 19.3.1.3. Company Hematology Drugs Market Products And Services
      • 19.3.1.4. Financial Performance
    • 19.3.2. Shire Plc
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Company Hematology Drugs Market Structure And Strategy
      • 19.3.2.3. Company Hematology Drugs Market Products And Services
      • 19.3.2.4. Financial Performance
    • 19.3.3. Bayer AG
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Company Hematology Drugs Market Structure And Strategy
      • 19.3.3.3. Company Hematology Drugs Market Products And Services
      • 19.3.3.4. Financial Performance
    • 19.3.4. Daiichi Sankyo Company
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Company Hematology Drugs Market Structure And Strategy
      • 19.3.4.3. Company Hematology Drugs Market Products And Services
      • 19.3.4.4. Financial Performance
    • 19.3.5. Biogen Inc
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Company Hematology Drugs Market Structure And Strategy
      • 19.3.5.3. Company Hematology Drugs Market Products And Services
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Hematology Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022 Growth, by segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Hematology Drugs Market In 2022- Growth Countries
  • 22.2. Global Hematology Drugs Market In 2022- Growth Segments
  • 22.3. Global Hematology Drugs Market In 2022- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer

Back to Top